Bio-Techne (TECH) Goodwill & Intangibles (2009 - 2026)
Bio-Techne (TECH) posted quarterly Goodwill & Intangibles of $1.9 billion for Q1 2026, up 32.67% year-over-year from $1.4 billion in Q1 2025, and up 42.43% quarter-over-quarter from $1.3 billion in Q4 2025.
Analysis
Bio-Techne (TECH) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Bio-Techne's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $1.9 billion for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 32.67% year-over-year to $1.9 billion; the TTM figure through Mar 2026 stood at $1.9 billion (up 32.67% YoY), while the FY2025 annual figure was $1.3 billion, up 29.59% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $1.9 billion, up from $1.3 billion in the prior quarter.
- The five-year high for Goodwill & Intangibles was $1.9 billion in Q1 2026, with the low at $27.1 million in Q1 2022.
- The 5-year median for Goodwill & Intangibles is $1.3 billion (2025), against an average of $1.2 billion.
- Peak annual rise in Goodwill & Intangibles reached 3195.24% in 2023, while the deepest fall reached 53.03% in 2023.
- Bio-Techne's Goodwill & Intangibles stood at $945.2 million in 2022, then soared by 59.54% to $1.5 billion in 2023, then fell by 5.46% to $1.4 billion in 2024, then dropped by 7.72% to $1.3 billion in 2025, then jumped by 42.43% to $1.9 billion in 2026.
- Business Quant data shows TECH's Goodwill & Intangibles at $1.9 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.87 Bn |
| Mar 31, 2026 | 1.87 Bn |
| Dec 31, 2025 | 1.88 Bn |
| Sep 30, 2025 | 1.88 Bn |
| Jun 30, 2025 | 1.98 Bn |
| Mar 31, 2025 | 2.02 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 30, 2024 | 1.47 Bn |
| Jun 30, 2024 | 1.48 Bn |
| Mar 31, 2024 | 628.97 Mn |
| Dec 31, 2023 | 653.15 Mn |
| Sep 30, 2023 | 681.53 Mn |
| Jun 30, 2023 | 1.41 Bn |
| Mar 31, 2023 | 604.31 Mn |
| Dec 31, 2022 | 618.70 Mn |
| Sep 30, 2022 | 636.59 Mn |
| Jun 30, 2022 | 1.35 Bn |
| Mar 31, 2022 | 555.75 Mn |
| Dec 31, 2021 | 1.40 Bn |
| Sep 30, 2021 | 1.46 Bn |